Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intepirdine + donepezil in mild-to-moderate Alzheimer's disease
NCT00710684Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of intepirdine in Alzheimer's disease (AD), sponsored by GSK. Started Jul 2008; status: completed.
02
Drugs
intepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00710684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710684.